Paradromics puts its Connexus brain implant into a speech-restoration patient
Matt Angle's Austin BCI company is moving from acute tests to a six-year study of whether neural signals can become speech.
By Ryan Merket · Published
Primary source: Business Insider
Why it matters
Paradromics is no longer only proving that Connexus can record brain signals in humans. It is testing whether a fully implantable BCI can become a long-term communication product for patients who cannot speak.
Paradromics founder and CEO Matt Angle has put the company's Connexus brain-computer interface into its first long-term speech-restoration patient, a Michigan woman with a motor neuron disease who has difficulty speaking, Business Insider reported.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.